Miguel Bioque Alcazar
CLINICAL AND PROVINCIAL HOSPITAL OF BARCELONA
Sant Pau Biomedical Research Institute
Spain
Biography
Miquel Bioque Alcázar is a specialist doctor in Psychiatry, Master in Clinical Research and Doctor in Medicine from the University of Barcelona. He develops his clinical and research activity in the Center of Biomedical Research in Mental Health Network in the Schizophrenia Unit of the Institute of Neurosciences of Hospital ClÃnic of Barcelona. His main line of research is currently focused on the study of inflammatory, immune and endocannabinoid system alterations in the early stages of psychotic disorders. He also works on projects focusing on the clinical characteristics and gene-environment interactions of the first and second psychotic episodes as well as pharmacogenetics and clinical trials.
Research Interest
Psychiatry
Publications
-
Bioque M1, Cabrera B2, GarcÃa-Bueno B3, Mac-Dowell KS3, Torrent C4, Saiz PA5, Parellada M6, González-Pinto A7, Lobo A8, Leza JC3, Bernardo M9; FLAMM-PEPs Study - Centro de Investigación Biomédica en Red de Salud Mental. Dysregulated peripheral endocannabinoid system signaling is associated with cognitive deficits in first-episode psychosis. J Psychiatr Res. 2016 Apr;75:14-21.
-
Miquel Bioque1, Borja GarcÃa-Bueno2,3, Karina S MacDowell2,3, Ana Meseguer1, Pilar A Saiz4, Mara Parellada5, Ana Gonzalez-Pinto6, Roberto Rodriguez-Jimenez3, Antonio Lobo7, Juan C Leza2,3 and Miguel Bernardo1,8 From the FLAMM-PEPs study—Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM). Peripheral Endocannabinoid System Dysregulation in First-Episode Psychosis. Neuropsychopharmacology (2013) 38, 2568–2577.
